Sharon Bio-Medicine Ltd

Next 500 2016
+ 1 More
+ 1 More
OVERVIEW
FINANCIALS

Featured In Fortune India Ranking

Next 500 India
#327(2016)#154(2015)
#327(2016)#154(2015)
Ranking Trend Fortune Next 500 India

Financial Data 2016

Revenue
134
(INR Cr)
Net Operating Income
253
(INR Cr)
Assets
656
(INR Cr)
Profit
-300
(INR Cr)
Net Worth
-181
(INR Cr)

Financial Data

RevenueNet Operating IncomeProfitAssetsNet Worth
PARAMETERS201620152014201320122011201020092008
Revenue
(INR Cr)
134
-83.7%
820
-39.5%
1356
19.1%
1139
34.5%
846
26.9%
667
22.6%
544
12.6%
483
43.4%
337
-
Net Operating Income
(INR Cr)
253
-69.77%
838
-36.71%
1325
23.41%
1074
33.50%
804
28.29%
627
19.85%
523
24.58%
420
25.45%
335
0.00%
Profit
(INR Cr)
-300
-
-234
-
70
30.9%
54
25.6%
43
28.9%
33
48.6%
22
19.9%
19
-31.5%
27
-
Assets
(INR Cr)
656
-30.2%
940
-12.8%
1078
20.3%
896
26.6%
708
29.1%
548
16.9%
469
27.3%
369
21.5%
303
-
Net Worth
(INR Cr)
-181
-253.7%
118
-66.5%
352
40.0%
251
26.0%
200
-2.2%
204
61.5%
126
19.3%
106
19.4%
89
0.0%
Employee Cost
(INR Cr)
17
-16.7%
20
3.7%
19
30.3%
15
1.5%
15
9.1%
13
29.2%
10
86.4%
6
60.9%
3
-
Interest Cost
(INR Cr)
71945943342721147
Cash & Bank Balance
(INR Cr)
1016126642373
Total Debt
(INR Cr)
836821725644508344343262214

Key Financial Ratios

Profit As % Of RevenuesRONW %Interest Cost to EBITDA %ROCE %Debt to Equity Ratio
PARAMETERS201620152014201320122011201020092008
Profit As % Of Revenues --5.2%4.7%5.1%5.0%4.1%3.9%8.1%
Profit As % Of Assets --6.5%6.0%6.0%6.1%4.8%5.1%9.0%
Profit As % Of Networth --20.0%21.4%21.4%16.3%17.7%17.6%30.7%
Interest Cost to EBITDA % --37.2%35.6%35.7%37.1%39.5%37.0%16.9%
Debt to Equity Ratio -6.952.062.562.541.692.712.482.42
RONW --23.3%23.8%21.2%20.1%19.3%19.2%30.7%
ROCE 0.0%0.0%14.6%13.7%14.1%12.8%11.6%10.9%12.5%